Euro Coop Position on Antimicrobial Resistance
15.11.2016 17:50:43
In September 2016, the G20 recognised Antimicrobial Resistance as posing “a serious threat to public health, growth and global economic stability”. Antimicrobial Resistance or AMR occurs when microorganisms mutate and become resistant to antimicrobial drugs. As a consequence of these mutations, those medicines that are used currently become ineffective; the illness is prolonged and may even become life-threatening.
Current measures are not enough to counteract AMR. Euro Coop therefore calls on all stakeholders to play their part in order to tackle this important public health threat and to consider AMR as a priority globally.
Find out more about Euro Coop's position here.
Latest Consumer Policy news
Press release: Cooperative Vision for a Sustainable and Competitive Europe: Priorities for the 2024-2029 EU Term
On 5 November the “Cooperative Vision for a Sustainable and Competitive Europe:...
Join Us for a Cooperative Vision for a Sustainable and Competitive Europe
We are excited to invite you to our upcoming event, “Cooperative Vision for a Sustainable...
EU Auditors Urge Increased Commitment to Achieve Organic Farming Targets
The European Court of Auditors has recently issued a significant warning regarding the...
Latest Consumer Policy stories
Euro Coop Board Meeting in Turin: Celebrating 170 Years of Co-operation in Italy
On 7 November, the Euro Coop board meeting in Turin provided delegates with a chance to...
UN Unveils the 2025 International Year of Cooperatives Logo: Celebrating a Global Movement
The United Nations has officially launched the logo for the 2025 International Year of...
COOP Group Czech Republic Wins at IDC Digital Future Awards 2024
Coop Group in Czech Republic has been recognized for its forward-thinking digital innovation at...